CRBU FY 2023 Earnings — Caribou Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CRBUCaribou Biosciences, Inc.

$186M

FY 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$34M+148.9% YoY

Gross Profit

$31M89.8% margin

Operating Income

-$116M-336.6% margin

Net Income

-$102M-296.1% margin

EPS (Diluted)

$-1.38

Cash Flow

Operating Cash Flow

-$93M

Free Cash Flow

-$105M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$432M

Total Liabilities

$64M

Stockholders' Equity

$368M

Cash & Equivalents

$51M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$34M	$14M	+148.9%
Gross Profit	$31M	$10M	+203.2%
Operating Income	-$116M	-$106M	-9.1%
Net Income	-$102M	-$99M	-2.7%